Gynecologic cancer is cancer originating in the female reproductive organs. It includes cancers of the uterus, ovaries, cervix, fallopian tubes, vulva and vagina, and accounts for over 80,000 new cancers diagnosed in the US every year. Approximately half of these cases are uterine cancer. The risk of getting cancer increases with age, though inherited cancers due to gene mutations or a family history of cancer may increase the risk. Visit Clinical Cancer Genetics to learn more.
At Ohio State's Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, our treatment team is dedicated to providing the best care for women with or at ris for gynecologic cancer, both in the areas of treatment and research. With research and treatment areas under one roof, our physicians and researchers are better able to facilitate the translation of research advances to patient care.
As one of only four institutions approved by the National Cancer Institute (NCI) to conduct phase I and II clinical trials on NCI sponsored anticancer agents, the OSUCCC – James has access to more leading-edge targeted cancer therapies than most hospitals across America. That translates to better outcomes, fewer side effects and more hope. Search open cancer clinical trials.
This section of the Web site will give you access to:
If you have questions about gynecologic cancer, please call The James Line – a free cancer information resource and physician referral service – at 614-293-5066 or 1-800-293-5066 (outside Franklin County) or e-mail now. The James Line oncology nurses can be reached Monday-Friday 8:00 a.m.-5:00 p.m. (except weekends and holidays).